It’s Asthma and Allergy Awareness Month and the seasonal allergies category is as congested as ever. But a slew of patent expirations poses a greater concern than the fierce competition. By Ben Comer
Hay fever isn’t the only thing causing brand-name prescription manufacturers’ eyes to water this allergy season. Top-sell…
Denver, CO LegalView.com updated its mesothelioma blog with reports of an asbestos contamination that was concealed with piles of dirt by construction crews who were clearing the area for an affordable …
There are currently almost 20 million Americans suffering from asthma, and approximately 45 percent of these individuals are children, according to the National Heart Lung and Blood Institute (NHLBI).
Asthma is often associated with allergies, but not all individuals suffering from asthma also suffer from allergies. Asthma commonly begins during childhood and can be continue through to adulthood. However, all individuals are at risk for developing asthma at any age, and, i…
DOCTORS RATE Merck’s ePromotion efforts as tops in the industry, according to pharma marketing data firm Verispan.
Of the approximately 1,000 physicians who participated in “Verispan’s 2007 ePromotion Annual Study,” Merck was mentioned as a top company by 361, while the closest competitor, GlaxoSmithKline, was mentioned by 219 physicians. Fortyeight percent of primary care doctors …
Popular Prescription Drugs
Top 10 drugs prescribed by pediatricians in 2005
Drug Number of
Prescriptions
Singulair 4,556,000
Zithromax suspension 3,937,000
Omnicef 2,923,000
Concerta 2,904,000
Adderall XR …
M2 PRESSWIRE-14 December 2005-US Financial Network: Gilead Names John W. Madigan to Board and Merck Announces US Label Change for SINGULAIR(R)(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:14122005 City of Industry, CA - Biotechnology industry news provided by Finan…
Generic Singulair Montelukast is used for:
Prevention and long-term treatment of asthma. It is also used to relieve allergy symptoms. It may also be used for other conditions as determined by your doctor.
Generic Singulair Montelukast is a leukotriene receptor antagonist. It works by blocking a substance called leukotriene, which helps to decrease ce…
WHITEHOUSE STATION, N.J. — Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SINGULAIR(R) (montelukast sodium) for the relief of symptoms of perennial allergic rhinitis (PAR), or indoor allergies, in adults and children six months of age and older. A convenient once-a-day tablet, SINGULAIR has been proven to help relieve a broad ra…
Health & Pharmaceutical Writers
ADVISORY…for Thursday (Jan. 3)
NOTE TO EDITORS: Multimedia Assets Available With This Story
Include Photos, Text News Releases
–(BUSINESS WIRE)
Merck & Co. Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the leukotriene blocker SINGULAIR(R) (montelukast sodium) for the relief of symptoms of seasonal allergic…
